BMRA Stock Summary and Trading Ideas (Biomerica | NASDAQ:BMRA)

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.

Biomerica trades on the NASDAQ stock market under the symbol BMRA.

As of October 26, 2026, BMRA stock price climbed to $1.70 with 1,802 million shares trading.

BMRA has a beta of 1.27, meaning it tends to be more sensitive to market movements. BMRA has a correlation of 0.07 to the broad based SPY ETF.

BMRA has a market cap of $7.82 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, BMRA traded as high as $17.04 and as low as $1.45.

The top ETF exchange traded funds that BMRA belongs to (by Net Assets): VXF.

BMRA has underperformed the market in the last year with a price return of -41.6% while the SPY ETF gained +15.3%. However, in the short term, BMRA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +6.3% vs +4.1% return in SPY. But in the last 2 weeks, BMRA shares have been beat by the market, returning -7.4% compared to an SPY return of -1.5%.

BMRA support price is $1.59 and resistance is $1.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BMRA shares will trade within this expected range on the day.